LLY vs COR
By Alex · Tickerpine
Eli Lilly and Company vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | COR |
|---|---|---|
| Price | $1,443.50 | $359.03 |
| Market cap | $1.29T | $68.51B |
| P/E ratio | 46.9 | 20.0 |
| ROE | 86.02% | 129.01% |
| Profit margin | 31.90% | 1.03% |
| Revenue growth | 38.60% | 5.50% |
| Dividend yield | 0.48% | 0.74% |
| Beta | 0.39 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs COR in plain English
- LLY is the bigger company — about 18.8× the market cap of COR.
- COR is cheaper on earnings (P/E 20.0 vs 46.9).
- COR earns a higher return on equity (129% vs 86%).
- LLY is growing revenue faster (39% vs 6%).
- COR has the higher dividend yield (0.74% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.